Redox operates a full-service health data integration platform and vendor-agnostic API that standardizes and routes clinical data across a national network. Its network connects more than 1,400 healthcare delivery organizations and 350 digital health companies, exchanging over 12 million patient records per day across more than 50 EHR systems. Redox counts 95% of U.S. News & World Report’s Top Hospitals among its users and, as a Carequality Implementer, added access to more than 500,000 Carequality-enabled physicians. The company built rapid-deployment capabilities for telehealth (two-week integrations versus a typical 16–18 weeks), facilitates ELR reporting to 90% of state public health departments, and is the integration engine for roughly 10% of COVID tests processed nationwide via Curative. Redox plans to apply the new capital to accelerate product innovation, hire talent, and meet rising demand, and will announce enhancements to its standardized API at an upcoming product event. Financially, the company reported a 300% surge in integrations, surpassed 1,000 live connections in October 2020, and says funding to date tops $95 million. Redox offers a full-service interoperability platform that lets healthcare delivery organizations and technology vendors connect once and securely exchange data across a network. The platform standardizes inconsistent data formats and reduces redundant connections by exposing an intuitive, vendor-agnostic API and enforcing a consistent data model. Redox’s technology powers streamlined clinician workflows and enables use of targeted apps rather than one-size-fits-all systems, improving care delivery and patient experience. The company reports a rapidly growing network with more than 450 healthcare providers and hundreds of cloud-based applications using the Redox Interoperability Platform. Redox has been recognized by Gartner as a 2018 Cool Vendor for its networked interoperability model. Leadership frames the company mission around patient-centric infrastructure, summarized by the CEO’s internal motto, 'We are all patients.' Redox is a Madison, Wisconsin-based integration platform that provides an API allowing software to securely interoperate with electronic health records in health system infrastructure. Its API uses standardized data models and an interoperable network so applications connect to Redox once and can integrate with any health system and EHR. The platform has connected digital health applications to nearly 100 health systems across the country that utilize three dozen unique EHR vendors. The company is led by CEO Luke Bonney. Financially, Redox raised a $1M follow-on to its recently announced Series B, bringing that round's final close to $10M. The Series B was led by RRE Ventures with participation from .406 Ventures, HealthX Ventures, Flybridge Capital Partners, Dreamit Ventures and Intermountain Healthcare Innovation Fund. Redox provides an interoperable integration platform that simplifies healthcare data exchange and connectivity between digital health applications and a broad set of healthcare stakeholders. The network supports connections among healthcare organizations, HIEs, lab systems, payors, pharmaceutical companies, registries and technology providers, enabling secure sharing of data. Launched in 2014 by Luke Bonney (CEO) and Niko Skievaski (President), the company is headquartered in Madison, WI. Redox aims to accelerate its product roadmap with new funding to expand and enhance its platform capabilities. The article does not disclose operating metrics such as revenue or user counts. Financially, the company completed a $9m Series B to support these product and growth plans. Redox provides a platform that acts as a single access point for cloud-based healthcare applications to connect with electronic health records, offering access controls and monitoring while eliminating custom integrations. Its APIs and implementation services allow cloud vendors to sell to health systems and focus on application development. The company reports that over 120 applications currently use Redox as an integration partner. Redox was founded in 2014 by Luke Bonney and Niko Skievaski. The company closed a $3.5M Series A and will use the funds to expand operations. The financing strengthens its position as an interoperability layer between health systems and cloud applications.

Total raised

$92M

Funding rounds

5

Latest round

Series D

Latest activity

Feb 2021